Norcantharidin ameliorates estrogen deficient-mediated bone loss by attenuating the activation of extracellular signal-regulated kinase/ROS/NLRP3 inflammasome signaling

• Asıl Yazarlar: Guang Yang (Yazar), Huikang Xu (Yazar), Minjun Yao (Yazar), Shigui Yan (Yazar), Mengrui Wu (Yazar), Chenhe Zhou (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Osteoporosis, characterized by reduced bone mass, aberrant bone architecture, and elevated bone fragility, is driven by a disruption of bone homeostasis between bone resorption and bone formation. However, up to now, no drugs are perfect for osteoporosis treatment due to different defects. In this s...